• SPX
  • 5969.34
  • 0.35 %
  • 20.6299
  • DJI
  • 44296.51
  • 0.97 %
  • 426.1602
  • N225
  • 38283.85
  • 0.68 %
  • 257.6797
  • FTSE
  • 8262.08
  • 1.38 %
  • 112.8101
  • IXIC
  • 19003.65
  • 0.16 %
  • 31.2305
Boston Scientific Corporation (BSX) Stock Price, News & Analysis

Boston Scientific Corporation (BSX) Stock Price, News & Analysis

Currency in USD Disclaimer

$89.98

-$1.52

(-1.66%)

Day's range
$89.02
Day's range
$91.93
50-day range
$80.64
Day's range
$91.93
  • Country: US
  • ISIN: US1011371077
52 wk range
$53.93
Day's range
$91.93


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 5.45
  • Piotroski Score 4.00
  • Grade Outperform
  • Symbol (BSX)
  • Company Boston Scientific Corporation
  • Price $89.98
  • Changes Percentage (-1.66%)
  • Change -$1.52
  • Day Low $89.02
  • Day High $91.93
  • Year High $91.93

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 01/29/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $78.00
  • High Stock Price Target $118.00
  • Low Stock Price Target $48.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $1.19
  • Trailing P/E Ratio 64.8
  • Forward P/E Ratio 64.8
  • P/E Growth 64.8
  • Net Income $1.59 B

Income Statement

Quarterly

Annual

Latest News of BSX

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Boston Scientific Corporation Frequently Asked Questions

  • What were the earnings of BSX in the last quarter?

    In the last quarter Boston Scientific Corporation earnings were on Wednesday, October, 23rd. The Boston Scientific Corporation maker reported $0.63 EPS for the quarter, beating analysts' consensus estimates of $0.59 by $0.04.

  • What is the Boston Scientific Corporation stock price today?

    Today's price of Boston Scientific Corporation is $89.98 — it has decreased by -1.66% in the past 24 hours. Watch Boston Scientific Corporation stock price performance more closely on the chart.

  • Does Boston Scientific Corporation release reports?

    Yes, you can track Boston Scientific Corporation's financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Boston Scientific Corporation stock forecast?

    Watch the Boston Scientific Corporation chart and read a more detailed Boston Scientific Corporation stock forecast to see what analysts suggest you do with its shares.

  • What is Boston Scientific Corporation stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NYSE, exchange stock trades by Boston Scientific Corporation stock ticker.

  • How to buy Boston Scientific Corporation stocks?

    Like other stocks, BSX shares are sold on stock exchanges such as NYSE. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Boston Scientific Corporation's EBITDA?

    Boston Scientific Corporation measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Boston Scientific Corporation’s financial statements.

  • What is the Boston Scientific Corporation's net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0.1118679775, which equates to approximately 11.19%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Boston Scientific Corporation stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Boston Scientific Corporation's financials relevant news, and technical analysis. Boston Scientific Corporation's technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Boston Scientific Corporation stock currently indicates a “sell” signal. For more insights, review Boston Scientific Corporation’s technical analysis.

  • A revenue figure for Boston Scientific Corporation for its last quarter?

    Boston Scientific Corporation published it's last quarterly revenues at $4.21 B.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.